Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PI3K pathway analysis with everolimus + exemestane in metastatic breast cancer
2013-004120-11Phase 4Active
- Sponsor
- VU University Medical Center
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of everolimus and exemestane in breast cancer, sponsored by VU University Medical Center. Primary endpoints: Progression-free survival and Progression. Started Nov 2013; status: active.
02
Drugs
everolimusexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2013-004120-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004120-11.